Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

A distance-performance trade-off in the phenotypic basis of dispersal.

Addis BR, Tobalske BW, Davenport JM, Lowe WH.

Ecol Evol. 2019 Aug 22;9(18):10644-10653. doi: 10.1002/ece3.5583. eCollection 2019 Sep.

2.

Interspecific interactions are conditional on temperature in an Appalachian stream salamander community.

Hoffacker ML, Cecala KK, Ennen JR, Mitchell SM, Davenport JM.

Oecologia. 2018 Oct;188(2):623-631. doi: 10.1007/s00442-018-4228-x. Epub 2018 Jul 21.

PMID:
30032439
3.

Complex inter-Kingdom interactions: carnivorous plants affect growth of an aquatic vertebrate.

Davenport JM, Riley AW.

J Anim Ecol. 2017 May;86(3):484-489. doi: 10.1111/1365-2656.12652. Epub 2017 Mar 27.

PMID:
28191630
4.

Additive impacts of experimental climate change increase risk to an ectotherm at the Arctic's edge.

Davenport JM, Hossack BR, Fishback L.

Glob Chang Biol. 2017 Jun;23(6):2262-2271. doi: 10.1111/gcb.13543. Epub 2016 Nov 30.

PMID:
27790788
5.

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist.

Levy-Cooperman N, McIntyre G, Bonifacio L, McDonnell M, Davenport JM, Covington PS, Dove LS, Sellers EM.

J Pharmacol Exp Ther. 2016 Dec;359(3):471-481. Epub 2016 Sep 19.

6.

Eluxadoline for Irritable Bowel Syndrome with Diarrhea.

Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS.

N Engl J Med. 2016 Jan 21;374(3):242-53. doi: 10.1056/NEJMoa1505180.

7.

Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline.

Davenport JM, Covington P, Bonifacio L, McIntyre G, Venitz J.

J Clin Pharmacol. 2015 May;55(5):534-42. doi: 10.1002/jcph.442. Epub 2015 Jan 14.

8.

Partitioning the non-consumptive effects of predators on prey with complex life histories.

Davenport JM, Hossack BR, Lowe WH.

Oecologia. 2014 Sep;176(1):149-55. doi: 10.1007/s00442-014-2996-5. Epub 2014 Jun 26.

PMID:
24965938
9.

Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations.

Griffith KA, Couture DJ, Zhu S, Pandya N, Johantgen ME, Cavaletti G, Davenport JM, Tanguay LJ, Choflet A, Milliron T, Glass E, Gambill N, Renn CL, Dorsey SG.

Support Care Cancer. 2014 May;22(5):1161-9. doi: 10.1007/s00520-013-2068-0. Epub 2013 Dec 21.

10.

Nonconsumptive effects in a multiple predator system reduce the foraging efficiency of a keystone predator.

Davenport JM, Chalcraft DR.

Ecol Evol. 2013 Sep;3(9):3063-72. doi: 10.1002/ece3.691. Epub 2013 Aug 1.

11.

A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia.

Covington PS, Davenport JM, Andrae DA, Stryjewski ME, Turner LL, McIntyre G, Almenoff J.

J Antimicrob Chemother. 2013 Nov;68(11):2691-3. doi: 10.1093/jac/dkt217. Epub 2013 Jun 7. No abstract available.

12.

Developing a professional poster: four "ps" for advanced practice nurses to consider.

Bindon SL, Davenport JM.

AACN Adv Crit Care. 2013 Apr-Jun;24(2):169-76. doi: 10.1097/NCI.0b013e318287a3fb.

PMID:
23615014
13.

Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.

Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.

Gastroenterology. 2013 Aug;145(2):329-38.e1. doi: 10.1053/j.gastro.2013.04.006. Epub 2013 Apr 9.

14.

Summary of Pharmacokinetics and Tissue Distribution of a Broad-Spectrum Fluoroquinolone, JNJ-Q2.

Davenport JM, Covington P, Gotfried M, Medlock M, Watanalumlerd P, McIntyre G, Turner L, Almenoff J.

Clin Pharmacol Drug Dev. 2012 Oct;1(4):121-30. doi: 10.1177/2160763X12454714.

PMID:
27121454
15.

Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2.

Eichenbaum G, Pugsley MK, Gallacher DJ, Towart R, McIntyre G, Shukla U, Davenport JM, Lu HR, Rohrbacher J, Hillsamer V.

Br J Pharmacol. 2012 Jul;166(5):1694-707. doi: 10.1111/j.1476-5381.2012.01874.x.

16.

Evaluating the effects of trophic complexity on a keystone predator by disassembling a partial intraguild predation food web.

Davenport JM, Chalcraft DR.

J Anim Ecol. 2012 Jan;81(1):242-50. doi: 10.1111/j.1365-2656.2011.01906.x. Epub 2011 Sep 23.

PMID:
21950407
17.

Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.

Covington P, Davenport JM, Andrae D, O'Riordan W, Liverman L, McIntyre G, Almenoff J.

Antimicrob Agents Chemother. 2011 Dec;55(12):5790-7. doi: 10.1128/AAC.05044-11. Epub 2011 Sep 26.

19.
20.

Equivalence and superiority testing in regeneration clinical trials.

Gunsolley JC, Elswick RK, Davenport JM.

J Periodontol. 1998 May;69(5):521-7.

PMID:
9623894
21.

811 Charnley hips followed for 3-17 years.

Dall DM, Learmonth ID, Solomon M, Davenport JM.

Acta Orthop Scand. 1993 Jun;64(3):252-6.

PMID:
8322576
22.

Fracture and loosening of Charnley femoral stems. Comparison between first-generation and subsequent designs.

Dall DM, Learmonth ID, Solomon MI, Miles AW, Davenport JM.

J Bone Joint Surg Br. 1993 Mar;75(2):259-65.

PMID:
8444947
23.

Mechanical properties of heat-treated composite resin restorative materials.

Covey DA, Tahaney SR, Davenport JM.

J Prosthet Dent. 1992 Sep;68(3):458-61.

PMID:
1432761
24.

Survivorship of cemented total hip arthroplasty in patients 50 years of age or younger.

Solomon MI, Dall DM, Learmonth ID, Davenport JM.

J Arthroplasty. 1992;7 Suppl:347-52.

PMID:
1431915
25.

Effects of intrastromal corneal ring size and thickness on corneal flattening in human eyes.

Burris TE, Ayer CT, Evensen DA, Davenport JM.

Refract Corneal Surg. 1991 Jan-Feb;7(1):46-50.

PMID:
2043543
26.

The geography of health in South-East Mexico: a research study and agenda.

Prothero RM, Davenport JM.

Soc Sci Med. 1986;22(12):1321-7.

PMID:
3090708

Supplemental Content

Loading ...
Support Center